Development and Biological Characterization of a Novel Selective TrkA Agonist with Neuroprotective Properties against Amyloid Toxicity.
Rogdakis T, Charou D, Latorrata A, Papadimitriou E, Tsengenes A, Athanasiou C, Papadopoulou M, Chalikiopoulou C, Katsila T, Ramos I, Prousis KC, Wade RC, Sidiropoulou K, Calogeropoulou T, Gravanis A, Charalampopoulos I.
Rogdakis T, et al. Among authors: athanasiou c.
Biomedicines. 2022 Mar 6;10(3):614. doi: 10.3390/biomedicines10030614.
Biomedicines. 2022.
PMID: 35327415
Free PMC article.